Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberculosis | 4 | 2002 | 555 | 0.300 |
Why?
|
| Mycobacterium Infections | 2 | 1996 | 34 | 0.240 |
Why?
|
| Travel | 2 | 2017 | 129 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 209 | 0.150 |
Why?
|
| Myiasis | 1 | 1999 | 5 | 0.150 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 1997 | 5 | 0.130 |
Why?
|
| Antitubercular Agents | 6 | 2004 | 265 | 0.120 |
Why?
|
| Mothers | 1 | 2019 | 372 | 0.120 |
Why?
|
| Pneumonia, Bacterial | 1 | 1996 | 79 | 0.120 |
Why?
|
| Vagina | 1 | 2017 | 215 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2004 | 237 | 0.110 |
Why?
|
| RNA, Viral | 1 | 2017 | 512 | 0.110 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 178 | 0.110 |
Why?
|
| Coagulase | 1 | 1994 | 22 | 0.110 |
Why?
|
| Complement C3 | 1 | 1994 | 43 | 0.110 |
Why?
|
| Staphylococcus | 1 | 1994 | 68 | 0.110 |
Why?
|
| Iliac Vein | 1 | 1994 | 28 | 0.100 |
Why?
|
| Diagnosis, Differential | 5 | 2003 | 1916 | 0.100 |
Why?
|
| Femoral Vein | 1 | 1994 | 48 | 0.100 |
Why?
|
| Vaccination | 1 | 2019 | 1041 | 0.100 |
Why?
|
| Spinal Diseases | 1 | 1993 | 47 | 0.100 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 910 | 0.090 |
Why?
|
| Parents | 1 | 2019 | 1121 | 0.090 |
Why?
|
| Cat-Scratch Disease | 2 | 2003 | 28 | 0.090 |
Why?
|
| Pneumonia, Viral | 1 | 1996 | 380 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 1994 | 797 | 0.080 |
Why?
|
| Osteomyelitis | 1 | 1993 | 212 | 0.080 |
Why?
|
| Thrombosis | 1 | 1994 | 497 | 0.070 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 569 | 0.070 |
Why?
|
| Child | 14 | 2003 | 26349 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 4064 | 0.070 |
Why?
|
| Tuberculin Test | 3 | 2002 | 120 | 0.070 |
Why?
|
| Rifampin | 3 | 2003 | 122 | 0.060 |
Why?
|
| Cross Infection | 2 | 2002 | 339 | 0.060 |
Why?
|
| Child, Preschool | 9 | 2002 | 15081 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2004 | 81 | 0.050 |
Why?
|
| Tuberculosis, Cutaneous | 1 | 2003 | 4 | 0.050 |
Why?
|
| Humans | 21 | 2019 | 132012 | 0.050 |
Why?
|
| Bartonella henselae | 1 | 2003 | 16 | 0.050 |
Why?
|
| Infant, Newborn | 6 | 2001 | 8609 | 0.050 |
Why?
|
| Visitors to Patients | 1 | 2002 | 9 | 0.050 |
Why?
|
| Personnel, Hospital | 1 | 2002 | 33 | 0.050 |
Why?
|
| Pyrazinamide | 1 | 2002 | 10 | 0.050 |
Why?
|
| Directly Observed Therapy | 1 | 2002 | 25 | 0.050 |
Why?
|
| Antibiotics, Antitubercular | 1 | 2002 | 38 | 0.040 |
Why?
|
| Isoniazid | 1 | 2002 | 65 | 0.040 |
Why?
|
| Male | 12 | 2004 | 65403 | 0.040 |
Why?
|
| Female | 14 | 2019 | 71358 | 0.040 |
Why?
|
| Central America | 1 | 1999 | 22 | 0.040 |
Why?
|
| Spain | 1 | 2019 | 62 | 0.040 |
Why?
|
| Splenic Diseases | 1 | 1999 | 30 | 0.040 |
Why?
|
| Prognosis | 3 | 2003 | 4959 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2002 | 469 | 0.040 |
Why?
|
| Adult | 6 | 2019 | 31736 | 0.040 |
Why?
|
| Adolescent | 6 | 2019 | 21004 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 1489 | 0.030 |
Why?
|
| Therapeutic Equivalency | 1 | 1997 | 12 | 0.030 |
Why?
|
| Focal Infection | 1 | 1997 | 3 | 0.030 |
Why?
|
| Honduras | 1 | 2017 | 25 | 0.030 |
Why?
|
| Thrombophlebitis | 1 | 1997 | 19 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2017 | 81 | 0.030 |
Why?
|
| Vero Cells | 1 | 2017 | 114 | 0.030 |
Why?
|
| Motivation | 1 | 2019 | 332 | 0.030 |
Why?
|
| Saliva | 1 | 2017 | 138 | 0.030 |
Why?
|
| Age of Onset | 1 | 1997 | 630 | 0.030 |
Why?
|
| Zika Virus | 1 | 2017 | 156 | 0.030 |
Why?
|
| Liver Diseases | 1 | 1999 | 385 | 0.030 |
Why?
|
| Radiography | 1 | 1997 | 762 | 0.030 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 133 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 1995 | 83 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 1236 | 0.030 |
Why?
|
| Rhizopus | 1 | 1993 | 10 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 1997 | 287 | 0.030 |
Why?
|
| Incidence | 2 | 2004 | 3354 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 506 | 0.030 |
Why?
|
| Cellulitis | 1 | 1993 | 62 | 0.030 |
Why?
|
| Mucormycosis | 1 | 1993 | 31 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1994 | 191 | 0.020 |
Why?
|
| Pneumonia | 1 | 1996 | 342 | 0.020 |
Why?
|
| Infant | 5 | 2002 | 13336 | 0.020 |
Why?
|
| Sepsis | 1 | 1997 | 500 | 0.020 |
Why?
|
| Aspergillosis | 1 | 1992 | 46 | 0.020 |
Why?
|
| United States | 2 | 2017 | 11838 | 0.020 |
Why?
|
| Lung | 1 | 1997 | 1578 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6282 | 0.020 |
Why?
|
| Risk Factors | 2 | 1997 | 11011 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 10118 | 0.010 |
Why?
|
| Minnesota | 1 | 2004 | 180 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 2004 | 17739 | 0.010 |
Why?
|
| Patient Isolation | 1 | 2002 | 15 | 0.010 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2002 | 40 | 0.010 |
Why?
|
| Siblings | 1 | 2003 | 204 | 0.010 |
Why?
|
| Family Health | 1 | 2002 | 251 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 741 | 0.010 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2004 | 425 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 1227 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 34246 | 0.010 |
Why?
|
| Cats | 1 | 1999 | 121 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 1173 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 1487 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 800 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2003 | 13022 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 1997 | 150 | 0.010 |
Why?
|
| Abscess | 1 | 1997 | 139 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 3094 | 0.010 |
Why?
|
| Texas | 1 | 2002 | 3645 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 3714 | 0.010 |
Why?
|
| Necrosis | 1 | 1993 | 195 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1992 | 90 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1993 | 858 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1999 | 2578 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 28937 | 0.000 |
Why?
|